6.1.1: Insulin

Part of chapter 6 Endocrine System, section 6.1 Drugs used in diabetes

---

High-level prescribing trends for Insulin (BNF section 6.1.1) across The Pendle Medical Partnership for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

Chemicals

Biphasic insulin aspart (0601012W0)
Biphasic insulin lispro (0601012F0)
Biphasic isophane insulin (0601012D0)
Insulin aspart (0601011A0)
Insulin degludec (0601012Z0)
Insulin detemir (0601012X0)
Insulin glargine (0601012V0)
Insulin glargine/lixisenatide (0601012AB)
Insulin glulisine (0601011P0)
Insulin human (0601011R0)
Insulin Lispro (0601011L0)
Insulin zinc suspension (0601012G0)
Isophane insulin (0601012S0)
Protamine zinc insulin (0601012U0)
Soluble insulin (Neutral insulin) (0601011N0)